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ondary prevention of PTSD. We encourage the 
authors to continue interrogating their database 
to determine whether or not fentanyl and keta-
mine are as effective.
Jonathan Schofield, M.R.C.P.  
Andrew M. Johnston, M.R.C.P.I.  
Winston F. de Mello, F.R.C.A.
Joint Force Medical Group  
Camp Bastion, Afghanistan  
jschofield@doctors.org.uk
No potential conflict of interest relevant to this letter was re-
ported.
To the Editor: It seems curious that a sizable 
proportion of troops injured on the battlefield never 
received morphine or apparently any form of opioid 
analgesia. The article fails to offer an explanation 
for this finding. An analysis of the predictors for 
receiving morphine would be instructive with re-
gard to the relationship between morphine ad-
ministration and development of PTSD.
In addition to the proportion not receiving opi-
oid analgesia, the relatively low morphine dos-
ages provided raise the question of whether injured 
troops are getting adequate analgesia.
Andrew J. Saxon, M.D.
Veterans Affairs Puget Sound Health Care System  
Seattle, WA  
asaxon@uw.edu
Dr. Saxon reports receiving consulting fees from Reckitt 
Benckiser. No other potential conflict of interest relevant to this 
letter was reported.
The Authors Reply: With regard to the query 
raised by O’Connell and colleagues as to whether 
morphine was associated with any adverse out-
comes among patients treated at the facilities 
studied: no morphine-related adverse events or out-
comes were reported by care providers. O’Connell 
and colleagues also highlight an interesting and 
important area for future study — whether prefa-
cility opiate administration might affect PTSD 
rates. To our knowledge, there are very few com-
prehensive data available on the provision of pre-
hospital treatment after combat injury in Iraq; 
thus, it is not possible to investigate whether med-
ications administered before arrival at treatment 
facilities may also have been associated with a re-
duction in the risk of PTSD. However, an argument 
based on epidemiologic principles would suggest 
that misclassification errors of morphine admin-
istration status would be more likely to attenuate 
the odds ratios observed rather than artificially 
inflate them.
We agree that the association between PTSD 
and the “fragments from blast — NOS” mecha-
nism of injury is intriguing. But given the small 
number injuries in the study incurred through 
this mechanism, a more detailed analysis and ex-
panded database would be required to further 
elucidate the relationship between PTSD and blast-
related mechanisms of injury.
Schofield and colleagues bring attention to the 
important issue of a multimodal analgesic ap-
proach, including the use of fentanyl, ketamine, 
and benzodiazepines, to the care of severely in-
jured patients. Indeed, we are initiating a study in 
that regard.
Saxon brings up an interesting clinical issue 
relating to the care of combat casualties. We agree 
that further studies conducted to examine clini-
cal and injury-related predictors of morphine ad-
ministration during resuscitation would be a valu-
able new topic of research. However, the basis of 
clinical decision making on the use of analgesia 
in the area of acute trauma care and resuscita-
tion was outside the scope of this study.
Troy Lisa Holbrook, Ph.D.
EPI-SOAR Consulting  
San Diego, CA  
troy@epi-soar.com
Michael R. Galarneau, M.S.
Naval Health Research Center  
San Diego, CA
Since publication of their article, the authors report no fur-
ther potential conflict of interest. 
The opinions expressed here are those of the authors and do 
not necessarily represent those of the Department of the Navy 
or the Department of Defense.
Preoperative Drainage in Pancreatic Cancer
To the Editor: The study by van der Gaag et al. 
(Jan. 14 issue)1 comparing preoperative biliary 
drainage with surgery alone in patients with pan-
creatic cancer has some noteworthy limitations.
First, the trial design mandates a preoperative 
delay of 4 to 6 weeks after biliary drainage, as 
compared with surgery alone within 1 week. This 
protocol, which is based on less than persuasive 
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scientific evidence from studies in humans,2 pre-
cludes a fair comparison of the two study groups 
and disregards the usually unavoidable logistic 
requirement for treatment delay.3 A more infor-
mative trial design would have compared study 
groups with both equal and achievable waiting 
times for surgery (e.g., 2 to 4 weeks).
Second, the study protocol did not call for sys-
tematic use of endoscopic ultrasonography, an 
important tool in the diagnosis and staging of 
pancreatic cancer.4,5 This omission may well have 
accounted for the relatively high proportion of 
patients undergoing surgery who ultimately proved 
to have either benign or unresectable disease 
(39%).
Finally, the authors’ exclusion of patients with 
a bilirubin level of more than 250 μmol per liter 
(14.6 mg per deciliter) may have biased their re-
sults, since the excluded patients probably would 
have been at substantially higher risk for cholan-
gitis than those with lower values and therefore 
would have stood to gain a greater benefit from 
biliary drainage. The exclusion of these patients 
would make the study’s conclusions inapplicable 
to such patients.
Muhammad F. Dawwas, M.R.C.P. 
Martin W. James, M.R.C.P., Ph.D. 
Guruprasad P. Aithal, F.R.C.P., Ph.D.
Queen’s Medical Centre 
Nottingham, United Kingdom 
drdawwas@gmail.com
No potential conflict of interest relevant to this letter was re-
ported.
1. van der Gaag NA, Rauws EA, van Eijck CH, et al. Preopera-
tive biliary drainage for cancer of the head of the pancreas. 
N Engl J Med 2010;362:129-37.
2. Koyama K, Takagi Y, Ito K, Sato T. Experimental and clinical 
studies on the effect of biliary drainage in obstructive jaundice. 
Am J Surg 1981;142:293-9.
3. Lillemoe KD. Preoperative biliary drainage and surgical out-
come. Ann Surg 1999;230:143-4.
4. Baron TH, Mallery JS, Hirota WK, et al. The role of endos-
copy in the evaluation and treatment of patients with pancreati-
cobiliary malignancy. Gastrointest Endosc 2003;58:643-9.
5. Mallery S, Gupta K. Diagnosis and staging of solid pancre-
atic neoplasms. In: Gress F, Savides T, eds. Endoscopic ultra-
sonography. 2nd ed. Oxford, England: Wiley-Blackwell, 2009: 
110-28.
To the Editor: Van der Gaag et al. report that 
routine preoperative biliary drainage increased 
the rate of complications for patients undergoing 
surgery for cancer of the pancreatic head. How-
ever, several issues require discussion. First, im-
mediate biliary drainage is needed in acute sup-
purative cholangitis or deep obstructive jaundice 
(total bilirubin level, >15 mg per deciliter), which 
may lead to severe hepatic and immune dysfunc-
tion. A recent study confirmed that preoperative 
biliary drainage for ampullary cancer significantly 
reduced postoperative wound infection.1 Second, 
the use of long-term biliary drainage may have 
contributed to stent occlusion with secondary cho-
langitis that could explain most drainage-related 
complications in this study.2 Therefore, the in-
creased complication rate may be due to routine 
but unnecessary preoperative biliary drainage in 
the majority of patients and a prolonged duration 
of biliary stenting. Whether selected patients with 
deep jaundice could benefit from short-term pre-
operative biliary drainage deserves further inves-
tigation.
Chia-Chi Wang, M.D.
Buddhist Tzu Chi General Hospital 
Taipei, Taiwan
Jia-Horng Kao, M.D., Ph.D.
National Taiwan University College of Medicine 
Taipei, Taiwan 
kaojh@ntu.edu.tw
No potential conflict of interest relevant to this letter was re-
ported.
1. Abdullah SA, Gupta T, Jaafar KA, Chung YF, Ooi LL, Mes-
senas SJ. Ampullary carcinoma: effect of preoperative biliary 
drainage on surgical outcome. World J Gastroenterol 2009;15: 
2908-12.
2. Sewnath ME, Karsten TM, Prins MH, Rauws EJ, Obertop H, 
Gouma DJ. A meta-analysis on the efficacy of preoperative bil-
iary drainage for tumors causing obstructive jaundice. Ann Surg 
2002;236:17-27.
To the Editor: In the editorial accompanying 
the article by van der Gaag et al., Baron and Ko-
zarek1 conclude that a randomized, controlled 
trial should be conducted to compare preopera-
tive biliary drainage using self-expandable me-
tallic stents (SEMS) with surgery alone in patients 
with cancer of the pancreatic head. Since we have 
shown the superiority of covered SEMS over un-
covered SEMS for unresectable malignant biliary 
obstruction,2 it seems reasonable to consider the 
use of covered SEMS, rather than uncovered SEMS, 
as an attractive option in preoperative biliary 
drainage. However, on the basis of the findings 
of van der Gaag et al., we wonder whether a ran-
domized, controlled trial should be performed, 
as suggested by Baron and Kozarek. The use of 
SEMS could eliminate the risk of cholangitis and 
surgical complications from a palliative bypass. 
Nevertheless, the immediate endoscopic compli-
cations (e.g., bleeding and pancreatitis), which ac-
counted for 23% of complications related to pre-
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operative biliary drainage in the study, would not 
have been avoided and thus might not show the 
superiority of preoperative biliary drainage us-
ing SEMS.
Takeshi Tsujino, M.D., Ph.D.
Japanese Red Cross Medical Center 
Tokyo, Japan 
tsujinot-int@h.u-tokyo.ac.jp
Hiroyuki Isayama, M.D., Ph.D. 
Kazuhiko Koike, M.D., Ph.D.
University of Tokyo 
Tokyo, Japan
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ported.
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2. Isayama H, Komatsu Y, Tsujino T, et al. A prospective ran-
domised study of “covered” versus “uncovered” diamond stents 
for the management of distal malignant biliary obstruction. Gut 
2004;53:729-34.
To the Editor: Van der Gaag et al. conclude that 
preoperative biliary drainage in patients undergo-
ing surgery for cancer of the head of the pancreas 
increases complications. Previous studies have 
shown that stenting is associated with a doubling 
in the risk of wound infection and an overall 
slightly increased risk of any complication.1-3
Of note, the trial mandated a waiting period 
of 4 to 6 weeks after biliary drainage, which is not 
typical practice. It is unclear whether patients 
who underwent biliary drainage received peripro-
cedural antibiotics. In addition, the significantly 
higher body-mass index in the drainage group 
would predict a higher complication rate.4 What 
size of biliary endoprosthesis was mandated? Size 
7-French plastic stents occlude more frequently 
than do size 10-French plastic stents. Metallic en-
doprostheses occlude much less frequently, and 
despite statements to the contrary, they can be 
removed at the time of resection.
In this era of cost consciousness, should pa-
tients with obstructive jaundice and periampul-
lary neoplasia be endoscopically manipulated? Or 
if imaging shows resectable periampullary neo-
plasia, should the patients undergo early surgery? 
In most cases, we favor the latter.
Eugene P. Kennedy, M.D. 
Ernest L. Rosato, M.D. 
Charles J. Yeo, M.D.
Thomas Jefferson University 
Philadelphia, PA 
charles.yeo@jefferson.edu
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3. Pisters PW, Hudec WA, Hess KR, et al. Effect of preoperative 
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morbidity in 300 consecutive patients. Ann Surg 2001;234:47-
55.
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To the Editor: I would like to know the ration-
ale behind administering antibiotics routinely be-
fore surgery but leaving their use “up to local 
policy of the hospital’s endoscopist performing 
ERCP [endoscopic retrograde cholangiopancrea-
tography],” as stated in the article by van der Gaag 
et al. I suggest that the failure to use antibiotic 
prophylaxis routinely before ERCP was a major 
factor increasing the risk of complications, with 
cholangitis representing the largest percentage 
(26%) of these. Whereas the use of antibiotics may 
not be warranted in patients in whom biliary 
drainage is likely to be successful, its use is war-
ranted for patients in whom the procedure has a 
high likelihood to fail, such as in the clinical set-
ting of the investigators, with success rates for 
initial drainage ranging from 69 to 83%. Current 
recommendations for the use of prophylactic an-
tibiotics in patients with biliary obstruction who 
are undergoing attempted endoscopic drainage 
call for using drugs that are excreted through the 
liver, such as ceftriaxone, piperacillin, and DNA 
gyrase inhibitors.1-3
Klaus Mönkemüller, M.D., Ph.D.
Otto von Guericke University 
Magdeburg, Germany 
klaus.moenkemueller@med.ovgu.de
No potential conflict of interest relevant to this letter was re-
ported.
1. Thompson BF, Arguedas ME, Wilcox CM. Antibiotic prophy-
laxis prior to endoscopic retrograde cholangiopancreatography 
in patients with obstructive jaundice: is it worth the cost? Ali-
ment Pharmacol Ther 2002;16:727-34.
2. Hirota WK, Petersen K, Baron TH, et al. Guidelines for anti-
biotic prophylaxis for GI endoscopy. Gastrointest Endosc 2003; 
58:475-82.
3. Mönkemüller K, Akbar Q, Fry LC. Use of antibiotics in ther-
apeutic endoscopy. Front Gastrointest Res 2010;27:9-17.
To the Editor: In the study by van der Gaag et 
al., the increased complication rate in the group 
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undergoing preoperative biliary drainage was from 
complications arising from stenting. Specifically, 
30% of patients receiving stents had to have their 
stents changed during the 5.2-week window be-
tween stent insertion and surgery. This rate of 
stent replacement (for occlusion or cholangitis) 
within such a short period is far in excess of others’ 
experience when using plastic stents in obstruct-
ing cancers of the pancreatic head.1 More infor-
mation should have been given about the type and 
size of plastic stents used. Presumably, the plas-
tic stents used were at least 10 French in size?
David A. Gorard, M.D.
Wycombe Hospital 
High Wycombe, United Kingdom 
david.gorard@buckshosp.nhs.uk
No potential conflict of interest relevant to this letter was re-
ported.
1. Moss AC, Morris E, MacMathuna P. Palliative biliary stents 
for obstructing pancreatic carcinoma. Cochrane Database Syst 
Rev 2006;2:CD004200.
The authors reply: Dawwas et al. suggest that 
a comparison of equal and shorter waiting times 
for surgery (2 to 4 weeks) would be more infor-
mative. We evaluated the presumptive therapeu-
tic benefit of routine biliary drainage. With re-
spect to the optimal interval between preoperative 
biliary drainage and surgery, as Wang and Kao 
discuss, the available literature suggests that a 
period of at least 4 to 6 weeks of drainage is need-
ed to reverse metabolic disorders and to yield any 
benefit.1,2 A longer period is unlikely to result in 
a better outcome but increases the risk of compli-
cations and unresectability. Whenever neoadju-
vant therapy is scheduled or logistic hurdles arise 
that preclude early surgical resection, preopera-
tive biliary drainage is indicated to bridge the 
time to surgery. Our study clearly shows that this 
strategy increases complications significantly. Ap-
proaches for avoiding such complications include 
performing early surgery or using techniques that 
allow for a higher stent patency. In response to 
the comments by Tsujino et al.: such higher pat-
ency is likely to be achieved with the use of SEMS 
that have a patency rate superior to that of plastic 
stents.
In response to the comments by Kennedy et al. 
and Mönkemüller: the standard-type plastic bil-
iary stent that we used in our study was size 10 
French. In accordance with a randomized, con-
trolled trial conducted at our center and current 
guidelines of the American Society for Gastroin-
testinal Endoscopy, centers in the Netherlands do 
not routinely administer prophylaxis for drainage 
in cases of obstruction of the distal bile duct. 
Such prophylaxis is reserved for cases with con-
trast filling of the bile duct but without ensuing 
biliary drainage or whenever incomplete drainage 
is anticipated in hilar strictures and primary scle-
rosing cholangitis.3,4
We used validated computed tomographic (CT) 
criteria to select patients for surgical exploration. 
Endoscopic ultrasonography was performed se-
lectively in patients with inconclusive findings on 
CT. The added value of endoscopic ultrasonogra-
phy after high-quality CT to assess vascular in-
growth is limited. Most patients present with a 
bilirubin level below 250 μmol per liter. Higher 
values are likely to be associated with profound 
hepatic impairment, and such patients may well 
benefit from preoperative biliary drainage, as is 
our current treatment strategy.
Like Gorard, we were surprised at the high rate 
of stent occlusion, with or without cholangitis, 
in our study. A possible explanation is that our 
patients had malignant distal disease, and for 
them the surgical intent was curative, rather than 
only palliative. Furthermore, high-volume expert 
centers report lower numbers of complications 
than we reported, but such results do not repre-
sent usual clinical practice, which is why our mul-
ticenter design also included community centers.5
Niels A. van der Gaag, M.D. 
Dirk J. Gouma, M.D., Ph.D.
Academic Medical Center 
Amsterdam, the Netherlands 
d.j.gouma@amc.uva.nl
Marco J. Bruno, M.D., Ph.D.
Erasmus Medical Center 
Rotterdam, the Netherlands
Since publication of their article, the authors report no fur-
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The editorialists reply: We agree with Tsujino 
et al. that the rates of bleeding and pancreatitis 
that were seen in this study could offset improve-
ment in outcome after endoscopic placement of 
SEMS in patients with obstructive jaundice and 
resectable cancer of the pancreatic head. Because 
preoperative drainage probably would not improve 
the postoperative outcome in such patients, any 
proposed study should be limited to those with se-
vere pruritus when surgery is delayed, those with 
cholangitis, or those receiving neoadjuvant thera-
py. We also stated that the ERCP success and com-
plication rates probably represent those seen in 
usual clinical practice. However, the complication 
rates were higher than expected. Size 10-French 
biliary stents and SEMS can be safely placed in 
patients with pancreatic cancer without perform-
ing biliary sphincterotomy.1,2 This approach would 
have eliminated bleeding. In addition, patients 
with pancreatic cancer who undergo ERCP for bil-
iary drainage are at low risk for post-ERCP pan-
creatitis, because most of these patients are older 
and transient obstruction of pancreatic ductal flow 
caused by edema at the level of the major papilla, 
a main cause of post-ERCP pancreatitis, is less im-
portant, since the main pancreatic duct is already 
obstructed by tumor.
Todd H. Baron, M.D.
Mayo Clinic 
Rochester, MN
Richard A. Kozarek, M.D.
Virginia Mason Medical Center 
Seattle, WA
Since publication of their article, the authors report no fur-
ther potential conflict of interest.
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Nosocomial Bacterial Meningitis
To the Editor: In their review of nosocomial 
bacterial meningitis, van de Beek et al. (Jan. 14 
issue)1 advocate for cerebrospinal fluid analysis 
as part of the diagnostic approach. We certainly 
agree that investigative study and empiric anti-
microbial therapy should be initiated promptly 
when the clinical suspicion is high. However, like 
others,2,3 we have previously reported that lum-
bar puncture should not be used indiscriminate-
ly, particularly given the low yield in the general 
hospitalized population and the possibility (al-
beit exceedingly low) of the development of iatro-
genic meningitis after the procedure.1 Indeed, it 
appears that the probability of nosocomial bacte-
rial meningitis may be defined primarily by pa-
tient history (e.g., recent head trauma, neurosur-
gical procedures, or immunosuppression), as 
supported by the authors’ previous work,4 and 
lumbar puncture may be reasonably deferred in 
the absence of clear preexisting risk factors.
In addition, the authors neglected to mention 
the use of external ventricular drain catheters 
impregnated with antibiotics, which have been 
shown to lower the risk of infection significant-
ly.5 Given the considerable morbidity associated 
with the complication of meningitis after ven-
tricular catheter placement, these devices should 
be considered as part of a prevention strategy.
William L. Jackson, Jr., M.D.
Inova Health System  
Falls Church, VA  
william.jackson@inova.org
Andrew F. Shorr, M.D., M.P.H.
Washington Hospital Center  
Washington, DC
No potential conflict of interest relevant to this letter was re-
ported.
1. van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial 
meningitis. N Engl J Med 2010;362:146-54.
2. Jackson WL Jr, Shorr AF. The yield of lumbar puncture to 
exclude nosocomial meningitis as aetiology for mental status 
changes in the medical intensive care unit. Anaesth Intensive 
Care 2006;34:21-4.
3. Adelson-Mitty J, Fink MP, Lisbon A. The value of lumbar 
puncture in the evaluation of critically ill, non-immunosup-
pressed, surgical patients: a retrospective analysis of 70 cases. 
Intensive Care Med 1997;23:749-52.
4. Weisfelt M, van de Beek D, Spanjaard L, de Gans J. Nosoco-
mial bacterial meningitis in adults: a prospective series of 50 
cases. J Hosp Infect 2007;66:71-8.
5. Zabramski JM, Whiting D, Darouiche RO, et al. Efficacy of 
antimicrobial-impregnated external ventricular drain catheters: 
a prospective, randomized, controlled trial. J Neurosurg 2003; 
98:725-30.
To the Editor: We are concerned that van de 
Beek and colleagues suggest that a serum con-
centration of vancomycin of only 15 to 20 μg per 
milliliter constitutes efficient first-line therapy for 
nosocomial bacterial meningitis. Admittedly, these 
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